[Long-term results of chemotherapy of newly detected patients with destructive pulmonary tuberculosis].
Explore the source record for details and available documents.
Biomedical subjects
Publications and source records attributed to S M Roslik.
Explore the source record for details and available documents.
The authors present an analysis of dynamic five-year follow-up of 141 patients with freshly detected destructive pulmonary tuberculosis that received treatment with isoniaside and rifampicin in combination with other drugs. It was found that reactivation of pulmonary tuberculosis with the use of rifampicin is observed in 11 +/- 5% of patients and is accompanied by phenomena of not infrequently marked intoxication and chest symptoms and complaints. The importance of timing the main course of chemotherapy (not less than 12 months) and regular prophylactic autumn-spring course of treatment in the prophylaxis of reactivations of pulmonary tuberculosis.
Explore the source record for details and available documents.
Examination in 34875 children and adults revealed in 15.2% positive tuberculin reactions. In 0.23% these reactions were of hyperergic character. The authors present a detailed clinico-roentgenological characterization of these hyperergic reaction. The effect was established of BCG vaccination, contact of patients with tuberculosis, chronic infection foci on the skin sensitivity to tuberculin.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.